Device Center Extramural PMA Review Contracting Supported By Feigal
This article was originally published in The Gray Sheet
Executive Summary
FDA should allow manufacturers to pay "outside experts" to review all or part of their premarket approval applications, according to a proposal being advanced by device industry groups